{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["333(7565)"],"submitter":["Ho KM"],"pubmed_abstract":["<h4>Objective</h4>To investigate the potential beneficial and adverse effects of frusemide to prevent or treat acute renal failure in adults.<h4>Design</h4>Meta-analysis of randomised controlled trials.<h4>Data sources</h4>Cochrane controlled trials register (2005 issue 4), Embase, and Medline (1966 to 1 February 2006), without language restrictions.<h4>Review methods</h4>Two reviewers checked the quality of the studies and independently extracted data.<h4>Results</h4>Nine randomised controlled trials totalling 849 patients with or at risk of acute renal failure were included. Outcome measures not significantly different after frusemide treatment were in-hospital mortality (relative risk 1.11, 95% confidence interval 0.92 to 1.33), risk for requiring renal replacement therapy or dialysis ("],"journal":["BMJ (Clinical research ed.)"],"pagination":["420"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC1553510"],"repository":["biostudies-literature"],"pubmed_title":["Meta-analysis of frusemide to prevent or treat acute renal failure."],"pmcid":["PMC1553510"],"pubmed_authors":["Ho KM","Sheridan DJ"],"additional_accession":[]},"is_claimable":false,"name":"Meta-analysis of frusemide to prevent or treat acute renal failure.","description":"<h4>Objective</h4>To investigate the potential beneficial and adverse effects of frusemide to prevent or treat acute renal failure in adults.<h4>Design</h4>Meta-analysis of randomised controlled trials.<h4>Data sources</h4>Cochrane controlled trials register (2005 issue 4), Embase, and Medline (1966 to 1 February 2006), without language restrictions.<h4>Review methods</h4>Two reviewers checked the quality of the studies and independently extracted data.<h4>Results</h4>Nine randomised controlled trials totalling 849 patients with or at risk of acute renal failure were included. Outcome measures not significantly different after frusemide treatment were in-hospital mortality (relative risk 1.11, 95% confidence interval 0.92 to 1.33), risk for requiring renal replacement therapy or dialysis (","dates":{"release":"2006-01-01T00:00:00Z","publication":"2006 Aug","modification":"2025-04-19T13:09:24.457Z","creation":"2019-03-27T01:45:47Z"},"accession":"S-EPMC1553510","cross_references":{"pubmed":["16861256"],"doi":["10.1136/bmj.38902.605347.7C","10.1136/bmj.38902.605347.7c"]}}